Midazolam dose is associated with recurrence of paradoxical reactions during endoscopy

doi:10.12998/wjcc.v9.i29.8763

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 29

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8025)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-3) series.

Item

Count

PDF

284

WORD

136

HTML

5824

Figures (1-2)

231

Tables (1-3)

504

Sum=6979

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

397

Download

649

Sum=1046

Oct 16, 2021 (publication date) through Nov 26, 2024

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Clin Cases. Oct 16, 2021; 9(29): 8763-8772
Published online Oct 16, 2021. doi: 10.12998/wjcc.v9.i29.8763

Full Size Figure Download Figure

Figure 2 In a multivariable analysis, this midazolam dose difference was an independent risk factor for recurrent paradoxical reactions.

Citation: Jin EH, Song JH, Lee J, Bae JH, Chung SJ. Midazolam dose is associated with recurrence of paradoxical reactions during endoscopy. World J Clin Cases 2021; 9(29): 8763-8772
URL: https://www.wjgnet.com/2307-8960/full/v9/i29/8763.htm
DOI: https://dx.doi.org/10.12998/wjcc.v9.i29.8763